DEERE & CO
DE · NYSE · CIK 0000315189
SIC 3523
Farm Machinery & Equipment
Category
Other
Entity
operating
Incorp.
DE
Fiscal Y/E
1101
Source: SEC EDGAR · All filings on SEC →
Business Overview
Source: SEC 10-K2 ITEM 1A. RISK FACTORS 14 ITEM 1B. UNRESOLVED STAFF COMMENTS 25 ITEM 1C. CYBERSECURITY 25 ITEM 2. PROPERTIES 26 ITEM 3. LEGAL PROCEEDINGS 27 ITEM 4. MINE SAFETY DISCLOSURES 27 ​ ​ ​ PART II ​ ​ ITEM 5. MARKET FOR REGISTRANT'S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES 27 ITEM 6. [RESERVED] 29 ITEM 7. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS 29 ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK 29 ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA 29 ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE 29 ITEM 9A. CONTROLS AND PROCEDURES 29 ITEM 9B. OTHER INFORMATION 29 ITEM 9C. DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS 29 ​ ​ ​ PART III ​ ​ ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE 30 ITEM 11. EXECUTIVE COMPENSATION 30 ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS 30 ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE 30 ITEM 14. PRINCIPAL ACCOUNTANT FEES AND SERVICES 30 ​ ​ ​ PART IV ​ ​ ITEM 15. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES 31 ITEM 16. FORM 10-K SUMMARY 31 ​ ​ ​ ​ 1 Table of Contents PART I ITEM 1. BUSINESS. This Annual Report on Form 10-K contains forward-looking statements that are subject to risks and uncertainties. All statements other than statements of historical fact included in this Annual Report on Form 10-K are forward-looking statements. Forward-looking statements provide our current expectations and projections relating to our financial condition, results of operations, plans, objectives, future performance, and business. You can identify forward-looking statements as they do not relate to historical or current facts and by words such as "believe," "expect," "estimate," "anticipate," "will," "aim," "should," "plan," "forecast," "target," "guide," "project," "intend," "could," and similar words or expressions. All forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially from those that we expected. Important factors that could cause actual results to differ materially from our expectations, or cautionary statements, and other important information about forward-looking statements are disclosed under Item 1A, "Risk Factors," and Item 7, "Management's Discussion and Analysis of Financial Condition and Results of Operations–Forward-Looking Statements," in this Annual Report on Form 10-K. As used herein, the terms "John Deere," "we," "us," "our," or "the Company" refer collectively to Deere & Company and its subsidiaries, unless designated or identified otherwise. All amounts are presented in millions of U.S. dollars, unless otherwise specified. Products John Deere has manufactured agricultural equipment since 1837. Deere & Company was incorporated under the laws of Delaware in 1958. Our business is managed through the following four business segments: Production & Precision Agriculture (PPA), Small Agriculture & Turf (SAT), Construction & Forestry (CF), and Financial Services (John Deere Financial or FS). ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ BUSINESS SEGMENT ​ PRODUCTION & PRECISION AGRICULTURE ​ SMALL AGRICULTURE & TURF ​ CONSTRUCTION & FORESTRY ​ FINANCIAL SERVICES PRODUCTS ​ ● 4WD/track and row crop tractors ● Harvesters ● Cotton Pickers and Cotton Strippers ● Sugarcane Harvesters ● Sugarcane Loaders ● Soil Preparation, Tillage, Seeding, Application, and Crop Care Equipment ​ ● Specialty, Utility, and Compact Tractors ● Self-Propelled Forage Harvesters and Attachments ● Hay and Forage Equipment ● Rotary Mowers ● Utility Vehicles ● Riding Lawn Equipment and Commercial Mowing Equipment ● Golf Course Equipment ​ ● Backhoe Loaders ● Crawler Dozers and Loaders ● Skid Steers ● Four-Wheel-Drive Loaders ● Compact Wheel Loaders ● Excavators and Compact Excavators ● Equipment used in Timber Harvesting ● Road Building and Road Rehabilitation Equipment ● Articulated Dump Trucks and Motor Graders ​ ● Retail Notes ● Revolving Charge Accounts ● Wholesale Receivables ● Leases ● Extended Warranties ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ CR
Investment Indicators
$592.67
-6.80 (-1.13%)
Open
$600.06
High
$602.60
Low
$590.63
Prev Close
$599.47
Volume
1,123,818
52W High
$672.22
52W Low
$430.25
50-day MA
$574.46
Quote as of: 2026-07-31
ROE
19.37%
Total Shareholder Yield
2.02%
Market Cap
$142.99B
P/E
30.03
P/B
5.22
PEG
1.63
EPS
17.63
BPS
101.47
Dividend Yield
1.22%
Beta
0.97
ROA
4.74%
D/E Ratio
3.08
Gross Margin
4.79%
Operating Margin
19.79%
Net Margin
11.00%
Book Value/Share
$95.97
Intrinsic Value Estimates
Multiple valuation methods, each with its own assumptions — outputs can diverge widely
Median consensus (7 methods)
$54.18B
Per-method implied market cap
| Method | Implied market cap | vs current |
|---|---|---|
Graham Number √(22.5 × 순이익 × 자본) | $54.18B | +164% |
Graham Formula 순이익 × (8.5 + 2 × 성장률%) | $42.73B | +235% |
Justified P/E 순이익 × 산업 평균 P/E | $75.41B | +90% |
P/B 배수 자본 × 산업 평균 P/B | $38.92B | +267% |
P/S 배수 매출 × 산업 평균 P/S | $91.37B | +57% |
DCF (Gordon) CF × (1+g) / (r − g) | $67.77B | +111% |
DDM (Gordon) D × (1+g) / (r − g) | $19.11B | +648% |
▶Detailed analysis — formula walk-through & scenarios
Why this conclusion
Of the 7 valuation methods, 7 were applicable. Their median fair-value lands +163.9% below the current market cap → the stock trades above most formulas' estimates (overvalued). 7 methods flag overvalued, 0 flag undervalued, the rest land within fair range. Read each formula's assumptions below before treating any single number as the answer.
Graham Number
Overvalued +163.9%√(22.5 × 순이익 × 자본)
What it measures · Benjamin Graham's conservative safety-margin formula. A high value requires both earnings and equity to be solid, so read it as 'the ceiling for a financially intact company.'
How it is computed · √(22.5 × NetIncome × Equity). 22.5 = max P/E 15 × max P/B 1.5 Graham would pay. Net income is latest FY consolidated net income from DART/XBRL; equity is total equity from the same filing.
When to trust it · Best for stable profitable industrials. Underestimates SaaS/platform/biotech because intangible-heavy businesses carry little book equity.
Current
$142.99B
Implied fair
$54.18B
Gap (current − fair)
+$88.82B(+163.9%)
NetIncome = $5.03B Equity = $25.95B √(22.5 × $5.03B × $25.95B) = $54.18B
- 최대 PER 15배
- 최대 PBR 1.5배
- 안정적 흑자 기업 가정 (금융·고성장 부정확)
Graham Formula
Overvalued +234.6%순이익 × (8.5 + 2 × 성장률%)
What it measures · Graham's 1962 revision that bakes growth into the multiple. Unlike the static Graham Number, this scales linearly with EPS growth so growth stocks aren't punished as hard.
How it is computed · NetIncome × (8.5 + 2g). 8.5 = base P/E for a zero-growth firm; 2g = +2× P/E for every 1pp of EPS growth. g is YoY EPS growth, clamped to [-5%, +25%] so a single big year doesn't blow up the estimate.
When to trust it · Works for firms with proven, somewhat stable growth. Misleading for first-year profits, swing years, or any period where g is distorted by a one-time charge or gain.
Current
$142.99B
Implied fair
$42.73B
Gap (current − fair)
+$100.26B(+234.6%)
NetIncome = $5.03B Growth g = -29.2% → cap -5.0% Multiple = 8.5 + 2 × -5.0 = -1.5× $5.03B × -1.5 = $-7.54B
- EPS 성장률 -29.2%/년 가정 (직전 1년 기준)
- 무성장 기업 P/E = 8.5
- 현재 적용 배수: 8.5x
Justified P/E
Overvalued +89.6%순이익 × 산업 평균 P/E
What it measures · Relative-value benchmark — "should trade at the industry average P/E." Not an absolute intrinsic value; tells you how the firm prices vs its peer set.
How it is computed · NetIncome × industry P/E. Defaults to a market-wide 15× when no industry multiple is provided. Net income is the latest FY consolidated net income.
When to trust it · Most reliable in mature industries with comparable peers (banks, telcos, utilities, refiners). Less useful for big-tech / hardware where industry P/Es span 10×–60×.
Current
$142.99B
Implied fair
$75.41B
Gap (current − fair)
+$67.59B(+89.6%)
NetIncome = $5.03B Industry P/E = 15× $5.03B × 15 = $75.41B
- 산업 평균 PER 15x 가정 (사용자 정의 가능)
- 동종 업종 비교가 핵심 — 산업별 평균 P/E 사용 권장
P/B 배수
Overvalued +267.4%자본 × 산업 평균 P/B
What it measures · Multiplies book equity by industry P/B to imply a fair market cap. Best for asset-heavy businesses (banks, insurers, brokers, REITs) where balance-sheet value is the franchise.
How it is computed · Total Equity × industry P/B. Defaults to 1.5×. Equity is total equity (or parent-owners share) from the latest balance sheet.
When to trust it · Strongest for banks/insurers — asset-liability matching is the business. Materially under-prices SaaS, platforms, and brand-heavy businesses where intangible value dwarfs book equity.
Current
$142.99B
Implied fair
$38.92B
Gap (current − fair)
+$104.07B(+267.4%)
Equity = $25.95B Industry P/B = 1.5× $25.95B × 1.5 = $38.92B
- 산업 평균 PBR 1.5x 가정
- 은행·보험·자산집약적 산업에 특히 유효
P/S 배수
Overvalued +56.5%매출 × 산업 평균 P/S
What it measures · Multiplies revenue by industry P/S. Useful when earnings are negative or noisy (early-stage, restructuring) — revenue stays positive.
How it is computed · Revenue × industry P/S. Defaults to 2.0×. Revenue is the latest FY consolidated top line.
When to trust it · Ignores margin structure — a 30% operating margin business and a -5% one get the same multiple. Only meaningful within peer + margin cohort.
Current
$142.99B
Implied fair
$91.37B
Gap (current − fair)
+$51.62B(+56.5%)
Revenue = $45.68B Industry P/S = 2× $45.68B × 2 = $91.37B
- 산업 평균 PSR 2x 가정
- 매출 기반 — 적자 기업·신생 기업에 적용 가능
- 이익률 차이 무시
DCF (Gordon)
Overvalued +111.0%CF × (1+g) / (r − g)
What it measures · Simplified Gordon-growth DCF — discounting perpetual cash flows. Extremely sensitive to the cash-flow / discount-rate / growth-rate inputs; trust the scenario grid more than the headline number.
How it is computed · FCF × (1+g) / (r − g). FCF preferred from XBRL/DART; falls back to NetIncome, then 5% of Revenue (rough proxy). Discount rate r = risk-free (4%) + equity premium (5%) = 9%. Growth g is EPS YoY clamped to [-2%, +6%], default 3%.
When to trust it · Strongest for steady, predictable businesses. When r-g approaches 0, the denominator blows up; near-perpetuity-growth combos are intentionally voided. Useless for cyclicals (semis, commodities, shipping) where g itself is noise.
Current
$142.99B
Implied fair
$67.77B
Gap (current − fair)
+$75.23B(+111.0%)
FCF = $6.10B Discount r = 4.0% + 5.0% = 9.0% Growth g = -2.0% $6.10B × (1 + -2.0%) / (9.0% − -2.0%) = $54.34B
- 현금흐름 입력: FCF (잉여현금흐름)
- 할인율 9.0% (무위험 4.0% + 주식위험프리미엄 5.0%)
- 영구 성장률 0.0% (0%~3% 범위 — 실질 GDP 한계)
DDM (Gordon)
Overvalued +648.2%D × (1+g) / (r − g)
What it measures · Values the firm purely on dividends paid to shareholders. Cleanest in theory, but only meaningful when management clearly intends to pay dividends — useless for share-repurchase-only payout policies.
How it is computed · D × (1+g) / (r − g). D from DART alotMatter (배당사항) or |CF dividendsPaid|. If absent, cascades to 30% of NetIncome (typical payout) → 30% of FCF → 1.5% of Revenue. r and g assumptions match DCF.
When to trust it · Most reliable for stable high-yielders (Korean utilities, tobacco, financial holdings). Sharply under-prices buyback-heavy firms (US big tech, parts of Korean IT) — look at the TSY column on the listing page to balance.
Current
$142.99B
Implied fair
$19.11B
Gap (current − fair)
+$123.88B(+648.2%)
Dividend D = $1.72B Discount r = 9.0% Growth g = -2.0% $1.72B × (1 + -2.0%) / (9.0% − -2.0%) = $15.32B
- 배당 입력: 실제 지급 배당
- 할인율 9.0%
- 배당 영구 성장률 0.0% (0%~3% 범위 — 실질 GDP 한계)
DCF sensitivity: discount rate × terminal growth
Each cell is the (current vs FCF × (1+g) / (r − g)) discount % under the assumed growth g and discount r.
| g \ r | 7% | 8% | 9% | 10% | 11% |
|---|---|---|---|---|---|
| 1% | +39.3% | +62.5% | +85.7% | +108.9% | +132.1% |
| 2% | +14.9% | +37.9% | +60.9% | +83.9% | +106.9% |
| 3% | -9.0% | +13.8% | +36.6% | +59.3% | +82.1% |
| 4% | -32.4% | -9.8% | +12.7% | +35.3% | +57.8% |
| 5% | -55.3% | -33.0% | -10.7% | +11.6% | +34.0% |
DDM sensitivity: discount rate × dividend growth
Each cell is the discount % vs Dividend × (1+g) / (r − g) under the assumed growth g and discount r.
| g \ r | 7% | 8% | 9% | 10% | 11% |
|---|---|---|---|---|---|
| 1% | +393.9% | +476.2% | +558.5% | +640.8% | +723.1% |
| 2% | +307.5% | +389.0% | +470.5% | +552.0% | +633.5% |
| 3% | +222.9% | +303.6% | +384.3% | +465.0% | +545.7% |
| 4% | +139.8% | +219.7% | +299.7% | +379.6% | +459.6% |
| 5% | +58.4% | +137.5% | +216.7% | +295.9% | +375.1% |
All estimates rest on strong assumptions. Treat the spread, not any single number, as the signal.
Showing the latest 5 years only
17 years of financials are available for this stock. Unlock the remaining 12 years (10+ year history) with Pro.
Upgrade to Pro · $1.99/moIn USD millions (per-share figures shown directly) · Financials as of: 2025-12-18
핵심 지표 FY 2025
ROE
19.37%
총주주수익률
2.02%
PER
30.03
PBR
5.22
PSR
3.13
PEG
1.63
EV/EBITDA
15.90
배당수익률
1.22%
ROA
4.74%
부채비율
3.08
매출총이익률
4.79%
영업이익률
19.79%
순이익률
11.00%
EPS
$17.63
BPS
$101.47
실적 추이
📄 SEC Filings
Current Report
8-K
2026-07-15
Open →
Current Report
8-K
2026-06-01
Open →
Quarterly Report
10-Q
2026-05-28
Open →
Current Report
8-K
2026-05-21
Open →
Current Report
8-K
2026-05-01
Open →
Current Report
8-K
2026-03-16
Open →
Current Report
8-K
2026-02-27
Open →
Quarterly Report
10-Q
2026-02-26
Open →
Current Report
8-K
2026-02-19
Open →
Current Report
8-K
2026-01-22
Open →
Proxy Statement
DEF 14A
2026-01-14
Open →
Annual Report
10-K
2025-12-18
Open →
Current Report
8-K
2025-12-04
Open →
Current Report
8-K
2025-11-26
Open →
Institutional Holdings
xslForm13F_X02/primary_doc.xml
2025-10-21
Open →
Current Report
8-K
2025-10-09
Open →
Current Report
8-K
2025-09-02
Open →
Quarterly Report
10-Q
2025-08-28
Open →
Current Report
8-K
2025-08-14
Open →
Institutional Holdings
xslForm13F_X02/primary_doc.xml
2025-07-23
Open →
Current Report
8-K
2025-07-07
Open →
Quarterly Report
10-Q
2025-05-29
Open →
Current Report
8-K
2025-05-15
Open →
Institutional Holdings
xslForm13F_X02/primary_doc.xml
2025-04-22
Open →
Current Report
8-K
2025-02-28
Open →
Quarterly Report
10-Q
2025-02-27
Open →
Other filings (74)
424B2
424B2
2026-07-13
Open →
FWP
FWP
2026-07-10
Open →
424B3
424B3
2026-07-10
Open →
S-3ASR
S-3ASR
2026-06-17
Open →
SD
SD
2026-05-18
Open →
3
xslF345X06/form3-05112026_030535.xml
2026-05-11
Open →
Insider Transaction
xslF345X06/form4-05042026_030541.xml
2026-05-04
Open →
SCHEDULE 13G
xslSCHEDULE_13G_X02/primary_doc.xml
2026-04-29
Open →
11-K
11-K
2026-03-31
Open →
11-K
11-K
2026-03-31
Open →
SCHEDULE 13G/A
xslSCHEDULE_13G_X02/primary_doc.xml
2026-03-26
Open →
Insider Transaction
xslF345X05/form4-03052026_090318.xml
2026-03-05
Open →
Insider Transaction
xslF345X05/form4-03052026_090306.xml
2026-03-05
Open →
Insider Transaction
xslF345X05/form4-03052026_090322.xml
2026-03-05
Open →
Insider Transaction
xslF345X05/form4-03052026_080310.xml
2026-03-05
Open →
Insider Transaction
xslF345X05/form4-03052026_080321.xml
2026-03-05
Open →
Insider Transaction
xslF345X05/form4-03052026_080359.xml
2026-03-05
Open →
Insider Transaction
xslF345X05/form4-03052026_080335.xml
2026-03-05
Open →
Insider Transaction
xslF345X05/form4-03052026_080321.xml
2026-03-05
Open →
Insider Transaction
xslF345X05/form4-03052026_080333.xml
2026-03-05
Open →
PX14A6G
w126261px14a6g.htm
2026-01-26
Open →
PX14A6G
NATIONAL LEGAL AND POLICY CENTER - PX14A6G
2026-01-20
Open →
Insider Transaction
xslF345X05/form4-01152026_060149.xml
2026-01-15
Open →
144
xsl144X01/primary_doc.xml
2026-01-14
Open →
ARS
ARS
2026-01-14
Open →
DEFA14A
DEFA14A
2026-01-14
Open →
Insider Transaction
xslF345X05/form4-01092026_080101.xml
2026-01-09
Open →
144
xsl144X01/primary_doc.xml
2026-01-08
Open →
Insider Transaction
xslF345X05/form4-12162025_081250.xml
2025-12-16
Open →
Insider Transaction
xslF345X05/form4-12162025_081215.xml
2025-12-16
Open →
Insider Transaction
xslF345X05/form4-12162025_081202.xml
2025-12-16
Open →
Insider Transaction
xslF345X05/form4-12162025_081213.xml
2025-12-16
Open →
Insider Transaction
xslF345X05/form4-12162025_081258.xml
2025-12-16
Open →
Insider Transaction
xslF345X05/form4-12162025_081210.xml
2025-12-16
Open →
Insider Transaction
xslF345X05/form4-12162025_071252.xml
2025-12-16
Open →
Insider Transaction
xslF345X05/form4-12162025_071247.xml
2025-12-16
Open →
Insider Transaction
xslF345X05/form4-12162025_071237.xml
2025-12-16
Open →
Insider Transaction
xslF345X05/form4-12132025_121252.xml
2025-12-12
Open →
Insider Transaction
xslF345X05/form4-12132025_121206.xml
2025-12-12
Open →
Insider Transaction
xslF345X05/form4-12132025_121219.xml
2025-12-12
Open →
Insider Transaction
xslF345X05/form4-12132025_121212.xml
2025-12-12
Open →
Insider Transaction
xslF345X05/form4-12132025_121222.xml
2025-12-12
Open →
Insider Transaction
xslF345X05/form4-12132025_121201.xml
2025-12-12
Open →
Insider Transaction
xslF345X05/form4-12122025_111217.xml
2025-12-12
Open →
Insider Transaction
xslF345X05/form4-12122025_111204.xml
2025-12-12
Open →
Insider Transaction
xslF345X05/form4-12122025_111238.xml
2025-12-12
Open →
Insider Transaction
xslF345X05/form4-12122025_111224.xml
2025-12-12
Open →
Insider Transaction
xslF345X05/form4-12112025_031206.xml
2025-12-11
Open →
3
xslF345X02/form3-12112025_121232.xml
2025-12-10
Open →
Insider Transaction
xslF345X05/form4-11262025_071124.xml
2025-11-26
Open →
144
xsl144X01/primary_doc.xml
2025-11-25
Open →
Insider Transaction
xslF345X05/form4-11032025_051131.xml
2025-11-03
Open →
424B2
424B2
2025-10-03
Open →
FWP
FWP
2025-10-02
Open →
424B3
424B3
2025-10-02
Open →
Insider Transaction
xslF345X05/form4-08182025_020857.xml
2025-08-18
Open →
Insider Transaction
xslF345X05/form4-06032025_030603.xml
2025-06-03
Open →
SD
SD
2025-05-16
Open →
Insider Transaction
xslF345X05/form4-05022025_020543.xml
2025-05-02
Open →
11-K
11-K
2025-03-27
Open →
11-K
11-K
2025-03-27
Open →
Insider Transaction
xslF345X05/form4-03062025_080302.xml
2025-03-06
Open →
Insider Transaction
xslF345X05/form4-03062025_080351.xml
2025-03-06
Open →
Insider Transaction
xslF345X05/form4-03062025_080340.xml
2025-03-06
Open →
Insider Transaction
xslF345X05/form4-03062025_080330.xml
2025-03-06
Open →
Insider Transaction
xslF345X05/form4-03062025_080322.xml
2025-03-06
Open →
Insider Transaction
xslF345X05/form4-03062025_080354.xml
2025-03-06
Open →
Insider Transaction
xslF345X05/form4-03062025_080326.xml
2025-03-06
Open →
Insider Transaction
xslF345X05/form4-03062025_080344.xml
2025-03-06
Open →
Insider Transaction
xslF345X05/form4-03062025_080317.xml
2025-03-06
Open →
Insider Transaction
xslF345X05/form4-03062025_080358.xml
2025-03-06
Open →
DEFA14A
DEFA14A
2025-02-24
Open →
Insider Transaction
xslF345X05/form4-02192025_100236.xml
2025-02-19
Open →
Insider Transaction
xslF345X05/form4-02192025_090238.xml
2025-02-19
Open →